Stockhub

Primary Health Properties PLC: Update: Difference between revisions

Page Discussion
No edit summary
No edit summary
 
(5 intermediate revisions by 4 users not shown)
Line 3: Line 3:
* Primary Health Properties, the FTSE 250 healthcare real estate investment company, has announced that Harry Hyman will officially step down as the company's chief executive officer (CEO) at the company's 2024 annual general meeting (AGM), which we estimate will take place between 1st April 2024 and 11th June 2024.
* Primary Health Properties, the FTSE 250 healthcare real estate investment company, has announced that Harry Hyman will officially step down as the company's chief executive officer (CEO) at the company's 2024 annual general meeting (AGM), which we estimate will take place between 1st April 2024 and 11th June 2024.
* The company previously indicated that Mr. Hyman will step down around that time, so the announcement is in-line with the market expectations.
* The company previously indicated that Mr. Hyman will step down around that time, so the announcement is in-line with the market expectations.
* Accordingly, we have maintained our forecasts, and estimate that the expected return of an investment in Primary Health Properties over the next 12-months is ccc%. In other words, an £100,000 investment in the company is expected to return £ccc in 12-months time.
* Accordingly, we have maintained our forecasts, continue to note that the degree of risk associated with an investment in Primary Health Properties is relatively low and remain of the view that the valuation of the company is attractive.
* We note that the degree of risk associated with an investment in Primary Health Properties is relatively 'low', with the company's shares having an adjusted beta<ref name=":0">Research shows that an investment has two main types of risks: 1) non-systematic and 2) systematic. Systematic risk is the risk related to the overall market, and non-systematic risk is the risk that's specific to an individual investment. Evidence shows that taking on non-systematic risk is inefficient, and it's, therefore, best to eliminate it; and in most cases, elimination is fairy easy to do [by holding a diversified portfolio of investments (i.e. around 15 investments)]. Accordingly, when assessing the riskiness of an investment, it’s best to look at the systematic risk only (i.e. ignore the non-systematic risk). A key measure of systematic risk is beta, and a main way to determine the riskiness of an investment is to compare the beta of the investment with the beta of the market, which is 1. For example, Sirius's adjusted beta (5 years, monthly data) is 1.06, and is, accordingly, 6% above the market beta (of 1); assuming that a 'low' level of riskiness is 10% or less above the market beta, then the riskiness of investing in the company is considered to be relatively 'low' (1.6%<10%). For estimating an asset's beta, in terms of time period, and frequency of observations, the most common choice is five years of monthly data, yielding 60 observations. In terms of the benchmark, we suggest using the iShares MSCI World ETF. One study of U.S. stocks found support for five years of monthly data over alternatives. The beta value in a future period has been found to be on average closer to the mean value of 1.0, the beta of an average-systematic-risk security, than to the value of the raw beta. Because valuation is forward looking, it is logical to adjust the raw beta so it more accurately predicts a future beta.</ref> that is 47% below the market (0.531 vs. 1).
*
* All-in-all, assuming that a suitable return level in the next 12 months is 10% or more, then an investment in the company is considered to be a 'suitable' one.
*


== Succession Planning ==
== Succession Planning ==
On 12th December 2022, the company announced that Harry Hyman will officially step down as the company's chief executive officer (CEO) at the company's 2024 annual general meeting (AGM), which, based on the dates of the company's last five AGMs, we estimate will take place between 1st April 2024 and 11th June 2024, and on a Wednesday.
On 12th December 2022, the company announced that Harry Hyman will officially step down as the company's chief executive officer (CEO) at the company's 2024 annual general meeting (AGM), which, based on the dates of the company's last five AGMs, we estimate will take place between 1st April 2024 and 11th June 2024. The company previously indicated that Mr. Hyman will step down around that time, so the announcement is in-line with the market expectations.
 
The company previously indicated that Mr. Hyman will step down around that time, so the announcement is in-line with the market expectations.  
 
The search for the next CEO is being led by the company's chairman and non-executive director Steven Owen. To help maintain the independence of a non-executive director position, the position is normally served by someone for a maximum nine years. For Mr. Owen, the nine years will elapse in January 2023; however, to ensure a smooth transition of the CEO position, he will remain as the chairman until the new CEO appointment, subject to shareholder approval. Also, he will remain a member of the Nomination Committee and ESG Committee until the appointment, and cease to be a member of the Remuneration Committee from 31<sup>st</sup> December 2022.
{| class="wikitable"
|+The dates of the company's last five AGMs
!#
!Date
!Day of the week
|-
|1
|27th April 2022
|Wednesday
|-
|2
|12th May 2021
|Wednesday
|-
|3
|1st April 2020
|Wednesday
|-
|4
|11th June 2019
|Tuesday
|-
|5
|18th April 2018
|Wednesday
|}
== Financials ==
== Financials ==


In light of the announcements, we have maintained our forecasts, which can be found by clicking [https://www.proactiveinvestors.co.uk/companies/news/989735/strong-first-half-2022-results-from-php-989735.html/long here].  
In light of the announcements, we have maintained our forecasts, which can be found by clicking [https://www.proactiveinvestors.co.uk/companies/news/989735/strong-first-half-2022-results-from-php-989735.html/long here].  
== Risks ==
== Risks ==
As with any investment, investing in Primary Health Properties carries a level of risk. Overall, based on the company's market beta (i.e. 0.531), the degree of risk associated with an investment in Primary Health Properties is relatively 'low'. Here, to estimate the adjusted beta, we used the iShares MSCI World ETF to represent the market portfolio; and in terms of the time period and frequency of observations, we used five years of monthly data (i.e. 60 observations in total), which is supported by a study and is the most common choice.
As with any investment, investing in Primary Health Properties carries a level of risk. Overall, based on the company's market beta (i.e. 0.531), the degree of risk associated with an investment in Primary Health Properties is relatively 'low'.  
 
Here, to estimate the adjusted beta, we used the iShares MSCI World ETF to represent the market portfolio; and in terms of the time period and frequency of observations, we used five years of monthly data (i.e. 60 observations in total), which is supported by a study and is the most common choice. The beta value in a future period has been found to be on average closer to the mean value of 1.0, and because valuation is forward looking, it is logical to adjust the raw beta so it more accurately predicts a future beta.


For us, currently, the biggest risk to the valuation of the company relates to macro-economic factors, in particular unexpected and sudden changes in inflation and interest rates movements.
For us, currently, the biggest risk to the valuation of the company relates to macro-economic factors, in particular unexpected and sudden changes in inflation and interest rates movements.


== Valuation ==
== Valuation ==
Research suggests that in terms of estimating the expected return of an investment over a period of 12-months or more, the approach that is more accurate is the absolute valuation approach, so that's the approach that we suggest using to determine the estimated value of the company.
Research suggests that in terms of estimating the expected return of an investment over a period of 12-months or more, the approach that is more/most accurate is the absolute valuation approach, so that's the approach that we suggest using to determine the estimated value of the company.


==== What's the expected return of an investment in Primary Health Properties using the absolute valuation approach? ====
==== What's the expected return of an investment in Primary Health Properties using the absolute valuation approach? ====
Accordingly, we estimate that the expected return of an investment in Primary Health Properties Plc over the next 12-months is ccc%. In other words, an £100,000 investment in the company is expected to return £ccc in 12-months from now. The assumptions used to estimate the return figure can be found in the table below.
Accordingly, we estimate that the expected return of an investment in Primary Health Properties Plc over the next 12-months is 59%. In other words, an £100,000 investment in the company is expected to return £159,000 in 12-months from now. The assumptions used to estimate the return figure can be found in the table below.


Assuming that a suitable return level in the 12 months is 10% and Primary Health Properties Plc achieves its expected return level (of ccc%), then an investment in the company is considered to be a 'suitable' one.
Assuming that a suitable return level in the 12 months is 10% and Primary Health Properties Plc achieves its expected return level (of 59%), then an investment in the company is considered to be a 'suitable' one.


==== What are the assumptions used to estimate the return figure? ====
==== What are the assumptions used to estimate the return figure? ====
Line 64: Line 36:
|Which valuation model do you want to use?
|Which valuation model do you want to use?
|Discounted cash flow
|Discounted cash flow
|A discounted cash flow model (also known as present value model) applied to equity valuation derives the value of common stock as the present or discounted value of its expected future cash flows (in private business appraisal, such models are known as income models of valuation).
|Research suggests that in terms of estimating the expected return of an investment over a period of 12-months or more, the approach that is more accurate is the absolute valuation approach, so that's the approach that we suggest using to determine the estimated value of the company.
|-
|-
|Which type of 'discounted cash flow model' do you want to use?
|Which type of discounted cash flow model do you want to use?
|Dividend discount model
|Dividend discount model
|For common stock, one familiar type of cash flow is dividends, which are discretionary distributions to shareholders authorized by a corporation’s board of directors. Dividends represent cash flows at the shareholder level in the sense that they are paid directly to shareholders. Present value models based on dividends are called dividend discount models.  
|The dividend discount model (DDM) is one of the most common discounted cash flow models.  
|-
|For the 'dividend discount model', which approach do you want to use?
|Forecast future dividends, by assigning the stream of future dividends to one of several stylized growth patterns
|
|-
|-
|For forecasting future dividends by assigning the stream of future dividends to one of several stylized growth patterns, how many distinct stage of growth do you want to use?
|How many distinct stage of growth do you want to use?
|One stage
|One stage
|For simplicity, we have used the one stage pattern here.
|For simplicity, we have used the one stage pattern here.
|-
|-
|For forecasting future dividends by assigning the stream of future dividends to one stage of growth, what is the expected constant growth rate in dividends?
|What is the expected constant growth rate in dividends?
|3%
|3%
|
|We note that the gross domestic product (GDP) growth rate in the last 20 years (2001 to 2022) is around 3% per year for the global economy, and around 2.25% for the United Kingdom. Over the last 10 years, the median dividend growth rate of the company is 2.78% and the mean is 3.47%.
|-
|-
|For forecasting future dividends by assigning the stream of future dividends to one stage of growth, what is the one-year forward expected dividend amount?  
|Which forecasts to use for the one-year ahead expected dividend amount?  
|Proactive Investors
|Proactive Investors
|
|Here, we have used the forecasts of Proactive Investors.
|-
|-
|For forecasting future dividends by assigning the stream of future dividends to one stage of growth, what is the required return on equity?
|What is the required return on equity?
|7%
|7%
|
|For estimating the required return on equity, we used the Capital Asset Pricing Model (CAPM), which provides an economically grounded and relatively objective procedure for required return estimation, and, therefore, it has been widely used in valuation. The calculation of the required return on equity (and the reasons behind the calculation) can be found in the table below.
|-
|-
|
|What's the current value of the company?
|
|108.9 pence per share
|
|As at 12th December 2022, the current value of Primary Health Properties Plc is 108.9p per share.
|}
 
{| class="wikitable"
|+Cost of equity (%)
!Input
!Input value
!Additional information
|-
|-
|
|Risk-free rate (%)
|
|3.55%
|
|Here, the risk free rate is the US 30 year treasury bond, and is calculated as at 12th December 2022.
|-
|-
|
|Beta
|
|0.531
|
|Here, to estimate the adjusted beta, we used the iShares MSCI World ETF to represent the market portfolio; and in terms of the time period and frequency of observations, we used five years of monthly data (i.e. 60 observations in total), which is supported by a study and is the most common choice. The beta value in a future period has been found to be on average closer to the mean value of 1.0, the beta of an average-systematic-risk security, than to the value of the raw beta; because valuation is forward looking, it is logical to adjust the raw beta so it more accurately predicts a future beta.
|-
|-
|Which financial forecasts to use?
|Equity risk premium (%)
|Proactive Investors
|6.00
|
|Here, the equity risk premium is in relation to the global region, and is calculated as at 1st January 2022 (<nowiki>https://pages.stern.nyu.edu/~adamodar/New_Home_Page/datafile/ctryprem.html</nowiki>).
|-
|-
|
|Cost of equity (%)
|
|6.74%
|
|Cost of equity = Risk-free rate + Beta x Equity risk premium.
|-
|
|
|
|-
|
|
|
|-
|Which type of multiple do you want to use?
|P/FFO
|The FFO does not account for depreciation in properties but rather adds back the depreciation value back to the net income. Furthmore, FFO deducts any gains or losses from the sale of assets, since including the transaction would result in discrepancies in the revenues reported in each period. Accordingly, we suggest valuing the company using the Price to Funds From Operations (P/FFO) ratio.
|-
|In regards to the P/FFO multiple, for the FFO figure, which year to you want to use?
|Twelve months ahead
|Research suggests that when using the relative valuation approach, it's best to use a time period of 12 months or less. Accordingly, for the FFO figure, we suggest using the twelve months ahead.
|-
|In regards to the P/FFO multiple, what multiple figure do you want to use?
|18x
|According to Bloomberg, Primary Health Properties Plc closest peers trade on a multiple of 18x.
|-
|Which financial forecasts to use?
|Proactive Investors
|Here, we have used the forecasts of Proactive Investors.
|-
|What's the current value of the company?
|£981.20 million
|As at 22nd November 2022, the current value of Primary Health Properties Plc is £981.20 million.
|-
|Which time period do you want to use to estimate the expected return?
|Between now and one year time
|Research suggests that when using the relative valuation approach, it's best to estimate the expected return of the company between now and one year time.
|}
|}
== Sensitive analysis ==
The three main inputs that result in the greatest change in the expected return of the Primary Health Properties Plc investment are, in order of importance (from highest to lowest):
The three main inputs that result in the greatest change in the expected return of the Primary Health Properties Plc investment are, in order of importance (from highest to lowest):


# The discount rate (the default multiple is 7%);
# The discount rate (the default multiple is 6.74%);
#The dividend growth rate (the default multiple is 3%); and
#The dividend growth rate (the default multiple is 2.78%); and
# The dividend per share forecast (the default forecast is 6.69 pence per share).
# The dividend per share forecast (the default forecast is 6.69 pence per share).


The impact of a 20% change in those main inputs to the expected return of the Primary Health Properties Plc investment is shown in the table below.
The impact of a 30% change in those main inputs to the expected return of the Primary Health Properties Plc investment is shown in the table below.
{| class="wikitable sortable"
{| class="wikitable sortable"
|+Primary Health Properties investment expected return sensitive analysis
|+Primary Health Properties investment expected return sensitive analysis
Line 157: Line 102:
|-
|-
|Discount rate
|Discount rate
|43%
|4%
|57%
|58%
|73%
|233%
|-
|Dividend per share
|11%
|58%
|106%
|-
|-
|Growth rate
|Growth rate
|
|28%
|
|58%
|
|106%
|-
|Dividend per share
|43%
|57%
|73%
|}
|}


== Appendix ==
== Appendix ==


==== What are the assumptions used to estimate the return figure? ====
=== Peers ===
{| class="wikitable"
|+Key inputs
!Description
!Value
!Commentary
|-
|Which type of multiple do you want to use?
|P/FFO
|The FFO does not account for depreciation in properties but rather adds back the depreciation value back to the net income. Furthmore, FFO deducts any gains or losses from the sale of assets, since including the transaction would result in discrepancies in the revenues reported in each period. Accordingly, we suggest valuing the company using the Price to Funds From Operations (P/FFO) ratio.
|-
|In regards to the P/FFO multiple, for the FFO figure, which year to you want to use?
|Twelve months ahead
|Research suggests that when using the relative valuation approach, it's best to use a time period of 12 months or less. Accordingly, for the FFO figure, we suggest using the twelve months ahead.
|-
|In regards to the P/FFO multiple, what multiple figure do you want to use?
|18x
|According to Bloomberg, Primary Health Properties Plc closest peers trade on a multiple of 18x.
|-
|Which financial forecasts to use?
|Proactive Investors
|Here, we have used the forecasts of Proactive Investors.
|-
|What's the current value of the company?
|£981.20 million
|As at 22nd November 2022, the current value of Primary Health Properties Plc is £981.20 million.
|-
|Which time period do you want to use to estimate the expected return?
|Between now and one year time
|Research suggests that when using the relative valuation approach, it's best to estimate the expected return of the company between now and one year time.
|}
Health Care REIT
{| class="wikitable"
{| class="wikitable"
|+Peers
|+Peers
Line 219: Line 133:
|Primary Health  Properties PLC
|Primary Health  Properties PLC
|PHP LN
|PHP LN
|
|United Kingdom
|1,459m
|1,459m
|0.168
|0.168
Line 228: Line 142:
|Assura PLC
|Assura PLC
|AGR LN
|AGR LN
|
|United Kingdom
|1,578m
|1,578m
| --
| --
Line 237: Line 151:
|Aedifica SA
|Aedifica SA
|AED BB
|AED BB
|
|Belgium
|2,660m
|2,660m
|14.8279
|14.8279
Line 246: Line 160:
|Target Healthcare REIT PLC
|Target Healthcare REIT PLC
|THRL LN
|THRL LN
|
|United Kingdom
|477m
|477m
| --
| --
Line 255: Line 169:
|Cofinimmo SA
|Cofinimmo SA
|COFB BB
|COFB BB
|
|Belgium
|2,340m
|2,340m
|11.3873
|11.3873
Line 264: Line 178:
|Impact Healthcare Reit PLC
|Impact Healthcare Reit PLC
|IHR LN
|IHR LN
|
|United Kingdom
|404m
|404m
|0.1111
|0.1111
Line 272: Line 186:
|}
|}


== Sensitive analysis ==
=== Other information ===
The two main inputs that result in the greatest change in the expected return of the Primary Health Properties Plc investment are, in order of importance (from highest to lowest):
Key things about the investment case of the company:
 
# The P/FFO multiple (the default multiple is 18x); and
# The twelve months ahead FFO forecast (the default forecast is €98.78 million).


The impact of a 10% change in those main inputs to the expected return of the Primary Health Properties Plc investment is shown in the table below.
* Dividend growth every year since inception (i.e. for 26 years).
{| class="wikitable sortable"
* 89% of rents are covered by government national health bodies of the UK and Ireland, supporting 99.7% occupancy rates and minimal tenant defaults or similar unplanned costs.
|+Primary Health Properties investment expected return sensitive analysis
* The lowest cost ratio (costs / rental income) in the whole of the UK REIT (real estate investment trust) space, with a EPRA (European Real Estate Association) cost ratio at 10.5%.
!Main input
* 95% of group debt is hedged for almost eight years.
!10% worse
* A quarter of rent roll is explicitly linked to inflation, and management argues that the balance is effectively linked to inflation through replacement cost.
!Unchanged
* Headroom to continue growing the portfolio of health centres.
!10% better
* An improving rental growth outlook, with rent reviews and asset management projects completed in the first half of this year adding £1.8m or 1.3% on a like-for-like basis.
|-
|The P/FFO multiple
|43%
|57%
|73%
|-
|The twelve months ahead FFO forecast
|43%
|57%
|73%
|}






Valuation


healthcare properties in the UK and Ireland.
The stock trades on 22.4x our FY22 earning forecast, which falls to 21.8x in FY23. On our forecasts, the dividend yields 4.5% this year, rising to 4.6% next year. We believe the valuation is attractive, given the strong track record, low operational risk profile and attractive business drivers.


=== Dividends ===
Over the last 10 years, the median dividend of the company is 2.78% and the mean is 3.47%.
{| class="wikitable"
{| class="wikitable"
|+Cost of equity (%)
|+Dividends
!Input
!Year
!Input value
!Q1
!Additional information
!Q2
!Q3
!Q4
!Total
!Growth (%)
|-
|2022
|1.625
|1.625
|1.625
|1.625
|6.5
|4.84%
|-
|2021
|1.55
|1.55
|1.55
|1.55
|6.2
|5.08%
|-
|2020
|1.475
|1.475
|1.475
|1.475
|5.9
|5.36%
|-
|2019
|1.4
|1.4
|1.4
|1.4
|5.6
|3.70%
|-
|2018
|1.35
|1.35
|1.35
|1.35
|5.4
|2.86%
|-
|2017
|1.31
|1.31
|1.31
|1.32
|5.25
|2.44%
|-
|2016
|1.28125
|1.28125
|1.28125
|1.28125
|5.125
|2.50%
|-
|-
|Risk-free rate (%)
|2015
|3.55%
|0
|Here, the risk free rate is the US 30 year treasury bond, and is calculated as at 12th December 2022.
|2.5
|0
|2.5
|5
|2.56%
|-
|-
|Beta
|2014
|0.531
|0
|
|2.4375
|0
|2.4375
|4.875
|2.63%
|-
|-
|Equity risk premium (%)
|2013
|5.26
|0
|Here, the equity risk premium is in relation to the global region, and is calculated as at 1st January 2022 (<nowiki>https://pages.stern.nyu.edu/~adamodar/New_Home_Page/datafile/ctryprem.html</nowiki>).
|2.375
|0
|2.375
|4.75
|2.70%
|-
|-
|Cost of equity (%)
|2012
|6.34%
|0
|Cost of equity = Risk-free rate + Beta x Equity risk premium.
|2.3125
|0
|2.3125
|4.625
|
|}
|}


== References and notes ==
== References and notes ==

Latest revision as of 13:50, 13 December 2022

SummaryEdit

  • Primary Health Properties, the FTSE 250 healthcare real estate investment company, has announced that Harry Hyman will officially step down as the company's chief executive officer (CEO) at the company's 2024 annual general meeting (AGM), which we estimate will take place between 1st April 2024 and 11th June 2024.
  • The company previously indicated that Mr. Hyman will step down around that time, so the announcement is in-line with the market expectations.
  • Accordingly, we have maintained our forecasts, continue to note that the degree of risk associated with an investment in Primary Health Properties is relatively low and remain of the view that the valuation of the company is attractive.

Succession PlanningEdit

On 12th December 2022, the company announced that Harry Hyman will officially step down as the company's chief executive officer (CEO) at the company's 2024 annual general meeting (AGM), which, based on the dates of the company's last five AGMs, we estimate will take place between 1st April 2024 and 11th June 2024. The company previously indicated that Mr. Hyman will step down around that time, so the announcement is in-line with the market expectations.

FinancialsEdit

In light of the announcements, we have maintained our forecasts, which can be found by clicking here.

RisksEdit

As with any investment, investing in Primary Health Properties carries a level of risk. Overall, based on the company's market beta (i.e. 0.531), the degree of risk associated with an investment in Primary Health Properties is relatively 'low'.

Here, to estimate the adjusted beta, we used the iShares MSCI World ETF to represent the market portfolio; and in terms of the time period and frequency of observations, we used five years of monthly data (i.e. 60 observations in total), which is supported by a study and is the most common choice. The beta value in a future period has been found to be on average closer to the mean value of 1.0, and because valuation is forward looking, it is logical to adjust the raw beta so it more accurately predicts a future beta.

For us, currently, the biggest risk to the valuation of the company relates to macro-economic factors, in particular unexpected and sudden changes in inflation and interest rates movements.

ValuationEdit

Research suggests that in terms of estimating the expected return of an investment over a period of 12-months or more, the approach that is more/most accurate is the absolute valuation approach, so that's the approach that we suggest using to determine the estimated value of the company.

What's the expected return of an investment in Primary Health Properties using the absolute valuation approach?Edit

Accordingly, we estimate that the expected return of an investment in Primary Health Properties Plc over the next 12-months is 59%. In other words, an £100,000 investment in the company is expected to return £159,000 in 12-months from now. The assumptions used to estimate the return figure can be found in the table below.

Assuming that a suitable return level in the 12 months is 10% and Primary Health Properties Plc achieves its expected return level (of 59%), then an investment in the company is considered to be a 'suitable' one.

What are the assumptions used to estimate the return figure?Edit

Key inputs
Description Value Commentary
Which valuation model do you want to use? Discounted cash flow Research suggests that in terms of estimating the expected return of an investment over a period of 12-months or more, the approach that is more accurate is the absolute valuation approach, so that's the approach that we suggest using to determine the estimated value of the company.
Which type of discounted cash flow model do you want to use? Dividend discount model The dividend discount model (DDM) is one of the most common discounted cash flow models.
How many distinct stage of growth do you want to use? One stage For simplicity, we have used the one stage pattern here.
What is the expected constant growth rate in dividends? 3% We note that the gross domestic product (GDP) growth rate in the last 20 years (2001 to 2022) is around 3% per year for the global economy, and around 2.25% for the United Kingdom. Over the last 10 years, the median dividend growth rate of the company is 2.78% and the mean is 3.47%.
Which forecasts to use for the one-year ahead expected dividend amount? Proactive Investors Here, we have used the forecasts of Proactive Investors.
What is the required return on equity? 7% For estimating the required return on equity, we used the Capital Asset Pricing Model (CAPM), which provides an economically grounded and relatively objective procedure for required return estimation, and, therefore, it has been widely used in valuation. The calculation of the required return on equity (and the reasons behind the calculation) can be found in the table below.
What's the current value of the company? 108.9 pence per share As at 12th December 2022, the current value of Primary Health Properties Plc is 108.9p per share.
Cost of equity (%)
Input Input value Additional information
Risk-free rate (%) 3.55% Here, the risk free rate is the US 30 year treasury bond, and is calculated as at 12th December 2022.
Beta 0.531 Here, to estimate the adjusted beta, we used the iShares MSCI World ETF to represent the market portfolio; and in terms of the time period and frequency of observations, we used five years of monthly data (i.e. 60 observations in total), which is supported by a study and is the most common choice. The beta value in a future period has been found to be on average closer to the mean value of 1.0, the beta of an average-systematic-risk security, than to the value of the raw beta; because valuation is forward looking, it is logical to adjust the raw beta so it more accurately predicts a future beta.
Equity risk premium (%) 6.00 Here, the equity risk premium is in relation to the global region, and is calculated as at 1st January 2022 (https://pages.stern.nyu.edu/~adamodar/New_Home_Page/datafile/ctryprem.html).
Cost of equity (%) 6.74% Cost of equity = Risk-free rate + Beta x Equity risk premium.

Sensitive analysisEdit

The three main inputs that result in the greatest change in the expected return of the Primary Health Properties Plc investment are, in order of importance (from highest to lowest):

  1. The discount rate (the default multiple is 6.74%);
  2. The dividend growth rate (the default multiple is 2.78%); and
  3. The dividend per share forecast (the default forecast is 6.69 pence per share).

The impact of a 30% change in those main inputs to the expected return of the Primary Health Properties Plc investment is shown in the table below.

Primary Health Properties investment expected return sensitive analysis
Main input 20% worse Unchanged 20% better
Discount rate 4% 58% 233%
Dividend per share 11% 58% 106%
Growth rate 28% 58% 106%

AppendixEdit

PeersEdit

Peers
Company name Bloomberg ticker Primary exchange Market capitalisation (GBP) BF P/FFO Yield (%) Interest cover (x) Total debt/total capital
Primary Health Properties PLC PHP LN United Kingdom 1,459m 0.168 5.95% N/A 46%
Assura PLC AGR LN United Kingdom 1,578m -- 5.77% 3.77 41%
Aedifica SA AED BB Belgium 2,660m 14.8279 4.75% 5.91 43%
Target Healthcare REIT PLC THRL LN United Kingdom 477m -- 8.78% 8.35 25%
Cofinimmo SA COFB BB Belgium 2,340m 11.3873 7.12% 7.80 44%
Impact Healthcare Reit PLC IHR LN United Kingdom 404m 0.1111 6.51% N/A 22%

Other informationEdit

Key things about the investment case of the company:

  • Dividend growth every year since inception (i.e. for 26 years).
  • 89% of rents are covered by government national health bodies of the UK and Ireland, supporting 99.7% occupancy rates and minimal tenant defaults or similar unplanned costs.
  • The lowest cost ratio (costs / rental income) in the whole of the UK REIT (real estate investment trust) space, with a EPRA (European Real Estate Association) cost ratio at 10.5%.
  • 95% of group debt is hedged for almost eight years.
  • A quarter of rent roll is explicitly linked to inflation, and management argues that the balance is effectively linked to inflation through replacement cost.
  • Headroom to continue growing the portfolio of health centres.
  • An improving rental growth outlook, with rent reviews and asset management projects completed in the first half of this year adding £1.8m or 1.3% on a like-for-like basis.


Valuation

The stock trades on 22.4x our FY22 earning forecast, which falls to 21.8x in FY23. On our forecasts, the dividend yields 4.5% this year, rising to 4.6% next year. We believe the valuation is attractive, given the strong track record, low operational risk profile and attractive business drivers.

DividendsEdit

Over the last 10 years, the median dividend of the company is 2.78% and the mean is 3.47%.

Dividends
Year Q1 Q2 Q3 Q4 Total Growth (%)
2022 1.625 1.625 1.625 1.625 6.5 4.84%
2021 1.55 1.55 1.55 1.55 6.2 5.08%
2020 1.475 1.475 1.475 1.475 5.9 5.36%
2019 1.4 1.4 1.4 1.4 5.6 3.70%
2018 1.35 1.35 1.35 1.35 5.4 2.86%
2017 1.31 1.31 1.31 1.32 5.25 2.44%
2016 1.28125 1.28125 1.28125 1.28125 5.125 2.50%
2015 0 2.5 0 2.5 5 2.56%
2014 0 2.4375 0 2.4375 4.875 2.63%
2013 0 2.375 0 2.375 4.75 2.70%
2012 0 2.3125 0 2.3125 4.625

References and notesEdit

Retrieved from ‘https://stockhub.co/index.php?title=Primary_Health_Properties_PLC:_Update&oldid=264089’